术中CT在大及巨大垂体腺瘤切除程度中的应用:发展中国家经验
该回顾性研究纳入30例经鼻内镜手术的大或巨大垂体腺瘤患者,评估术中CT(iCT)对切除程度的影响。iCT在13例中检出残余并促使进一步手术,巨大腺瘤的全切除率从43.8%提高至81.3%,大腺瘤从71%提高至86%。结论认为iCT可提高切除程度并促进最大安全切除。
要点
- iCT在30例中检出13例残余,其中巨大腺瘤9例、大腺瘤4例。
- iCT使巨大腺瘤全切除率从43.8%升至81.3%,大腺瘤从71%升至86%。
- 13例残余患者均未需超过2次iCT扫描,无术中并发症。
核心结论
- iCT可提高大及巨大垂体腺瘤的切除程度,促进全切除或近全切除等最大安全切除。
- iCT可能减少医源性并发症并在特定社会经济人群中具有选择性费用优势。
- 结论需进一步前瞻性对照研究证实。
研究设计与样本
- 回顾性综述,纳入采用经鼻内镜技术并使用iCT的垂体腺瘤病例。
- 共报告30例,包括14例大腺瘤和16例巨大腺瘤;14例无功能腺瘤和16例生长激素分泌腺瘤。
- 排除海绵窦侵犯患者;肿瘤按Hardy分类分级。
主要发现
- 总体全切除(GTR)、近全切除和次全切除率分别为83.3%、16.7%和3.3%。
- iCT在30例中13例检出残余,包括14例大腺瘤中4例(29%)和16例巨大腺瘤中9例(56.3%),促使进一步手术。
- iCT使巨大腺瘤GTR从43.8%提高至81.3%,大腺瘤从71%提高至86%。
- 13例iCT检出残余的患者中无一需要超过2次iCT扫描,未观察到术中并发症。
关键数值与推荐
- 总体GTR率83.3%,近全切除率16.7%,次全切除率3.3%。
- iCT检出残余:大腺瘤4/14(29%),巨大腺瘤9/16(56.3%)。
- iCT使用前后GTR:巨大腺瘤43.8%→81.3%,大腺瘤71%→86%。
临床怎么用
- 对大小及巨大垂体腺瘤经鼻内镜手术可考虑使用iCT以评估残余并指导进一步切除。
- iCT检出残余后进一步手术有助于提高全切除或近全切除率。
局限性
- 回顾性研究设计,样本量30例。
- 需进一步前瞻性对照研究证实结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The literature on the use of intraoperative computed tomography (iCT) is sparse. We provide our experience of the usefulness of iCT in extent of resection in large and giant pituitary adenomas. METHODS: A retrospective review was performed of cases using the endonasal endoscopic technique in which iCT was used. Demographic factors, number of scans, and impact on the extent of resection are reported, with visual acuity and field changes. Tumors were graded according to the Hardy classification. Patients with cavernous sinus invasion were excluded. RESULTS: All patients received a perioperative computed tomography scan with our iCT scanner. Thirty patients are reported, including 14 large and 16 giant pituitary adenomas, including 14 nonfunctional and 16 growth hormone-secreting tumors. The overall gross total resection (GTR), near-total resection, and subtotal resection rates were 83.3%, 16.7%, and 3.3%, respectively. iCT scanning detected residual in 13 of 30 patients, including 4 with 14 large (29%) and 9 with 16 (56.3%) giant adenomas promoting further surgery. iCT use improved GTR from 43.8% to 81.3% in giant adenomas and from 71% to 86% in large adenomas. Of the 13 patients in whom iCT detected residual disease, none required >2 iCT scans. No intraoperative complications were observed. CONCLUSIONS: iCT can improve extent of resection in large and giant pituitary adenomas and facilitate maximum safe resection such as GTR or near-total resection in patients where such should be attempted. iCT use may reduce iatrogenic complications and has select financial benefits in our patients' socioeconomic demographics. However, further prospective controlled studies are required to affirm our conclusions.
引用
- Ashraf M, Kamboh UA, Raza MA, et al. Usefulness of Intraoperative Computed Tomography on Extent of Resection of Large and Giant Pituitary Adenomas. Experience from a Developing Country. World Neurosurg. 2021. PMID: 34619403. doi:10.1016/j.wneu.2021.09.114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。